Mithra Pharmaceuticals SA - Company Profile
Powered by
All the data and insights you need on Mithra Pharmaceuticals SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Mithra Pharmaceuticals SA Strategy Report
- Understand Mithra Pharmaceuticals SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Mithra Pharmaceuticals SA patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US20220280189A1 | Application | INJECTOR SYSTEM FOR DELIVERY OF A MEDICAL IMPLANT | A61B17/3468; A61B2090/3987; A61M37/0069 | September 08, 2022 |
GEP20227407B | Grant | CONTRACEPTIVE COMPOSITION WITH REDUCED CARDIOVASCULAR EFFECTS | A61K31/565; A61P15/18 | August 25, 2022 |
ES2919626T3 | Grant | Régimen de tratamiento para el tratamiento de cáncer de mama avanzado positivo para el receptor de estrógenos | A61K31/565; A61K45/06; A61K9/0053; A61P35/00; A61P5/30 | July 27, 2022 |
GEP20227395B | Grant | COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS | A61K2300/00; A61K31/55; A61K31/565; A61K31/57; A61K31/573; A61K31/585; A61K45/06; A61K9/0053; A61P15/12; A61P5/30 | July 25, 2022 |
GEP20227396B | Grant | COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS | A61K2300/00; A61K31/55; A61K31/565; A61K31/57; A61K31/573; A61K31/585; A61K45/06; A61K9/0053; A61P15/12; A61P5/30 | July 25, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer